ABNX.PA
Price:
$3.89
Market Cap:
$135.04M
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metab...[Read more]
Industry
Biotechnology
IPO Date
2015-03-30
Stock Exchange
PAR
Ticker
ABNX.PA
According to ABIONYX Pharma S.A.’s latest financial reports and current stock price. The company's current ROE is -71.55%. This represents a change of 156.69% compared to the average of -27.87% of the last 4 quarters.
The mean historical ROE of ABIONYX Pharma S.A. over the last ten years is -65.83%. The current -71.55% ROE has changed 8.70% with respect to the historical average. Over the past ten years (40 quarters), ABNX.PA's ROE was at its highest in in the June 2019 quarter at 37.82%. The ROE was at its lowest in in the December 2014 quarter at -24533.33%.
Average
-65.83%
Median
-55.27%
Minimum
-170.23%
Maximum
27.74%
Discovering the peaks and valleys of ABIONYX Pharma S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 239.68%
Maximum Annual ROE = 27.74%
Minimum Annual Increase = -202.57%
Minimum Annual ROE = -170.23%
| Year | ROE | Change |
|---|---|---|
| 2024 | -59.27% | 33.46% |
| 2023 | -44.41% | -24.31% |
| 2022 | -58.67% | 7.59% |
| 2021 | -54.53% | 91.66% |
| 2020 | -28.45% | -202.57% |
| 2019 | 27.74% | -116.88% |
| 2018 | -164.32% | 193.39% |
| 2017 | -56.01% | -67.10% |
| 2016 | -170.23% | 239.68% |
| 2015 | -50.12% | -99.91% |
The current ROE of ABIONYX Pharma S.A. (ABNX.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-54.11%
5-year avg
-49.06%
10-year avg
-65.83%
ABIONYX Pharma S.A.’s ROE is less than OSE Immunotherapeutics S.A. (51.56%), greater than Innate Pharma S.A. (-658.91%), less than Adocia S.A. (180.00%), greater than Genfit S.A. (-63.70%), greater than Sensorion S.A. (-43.50%), greater than Transgene S.A. (-634.16%), less than Crossject S.A. (477.00%), greater than Cellectis S.A. (-49.81%), greater than MaaT Pharma S.A. (-334.21%), less than Median Technologies S.A. (90.19%),
| Company | ROE | Market cap |
|---|---|---|
| 51.56% | $112.67M | |
| -658.91% | $154.12M | |
| 180.00% | $137.97M | |
| -63.70% | $231.55M | |
| -43.50% | $91.64M | |
| -634.16% | $121.73M | |
| 477.00% | $112.71M | |
| -49.81% | $297.98M | |
| -334.21% | $62.87M | |
| 90.19% | $113.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABIONYX Pharma S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ABIONYX Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ABIONYX Pharma S.A.'s ROE?
How is the ROE calculated for ABIONYX Pharma S.A. (ABNX.PA)?
What is the highest ROE for ABIONYX Pharma S.A. (ABNX.PA)?
What is the 3-year average ROE for ABIONYX Pharma S.A. (ABNX.PA)?
What is the 5-year average ROE for ABIONYX Pharma S.A. (ABNX.PA)?
How does the current ROE for ABIONYX Pharma S.A. (ABNX.PA) compare to its historical average?